Skip to content

Safety and Efficacy of Simultaneous or Staged Surgery on Complicated Hepatolithiasis

A Cohort Study on Safety and Efficacy of Simultaneous or Staged Surgery in Complicated Hepatolithiasis

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03098264
Enrollment
92
Registered
2017-03-31
Start date
2017-04-11
Completion date
2018-12-31
Last updated
2017-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatolithiasis

Brief summary

For some complicated hepatolithiasis, it is difficult to decide whether to perform surgery on biliary stone and portal hypertension simultaneously or separately by staged surgery.There's a high risk of intraoperative bleeding, postoperative liver failure and variceal bleeding for these patients.How to develop a optimized algorism of simultaneous and staged surgery is highly needed.

Detailed description

For some complicated hepatolithiasis, it is difficult to decide whether to perform surgery on biliary stone and portal hypertension simultaneously or separately by staged surgery.There's a high risk of intraoperative bleeding, postoperative liver failure and variceal bleeding for these patients.How to develop a optimized algorism of simultaneous and staged surgery is highly needed. In this protocol, we will assign the eligible cases into two group. And then perform surgery as simultaneously or separately.By long-term follow-up,to examine the safety and advantages of each procedure.

Interventions

Simultaneous surgery in complicated hepatolithiasis

PROCEDUREstaged surgery

staged surgery in complicated hepatolithiasis

Sponsors

Second Affiliated Hospital, School of Medicine, Zhejiang University
CollaboratorOTHER
Chinese PLA General Hospital
CollaboratorOTHER
Eastern Hepatobiliary Surgery Hospital
CollaboratorOTHER
First Affiliated Hospital of Zhongshan Medical University
CollaboratorOTHER
Air Force Military Medical University, China
CollaboratorOTHER
Huaxi Hospital
CollaboratorOTHER
Tongji Hospital
CollaboratorOTHER
Union hospital of Fujian Medical University
CollaboratorOTHER
Southwest Hospital, China
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Aged from 18 to 65 years old * Without gender restriction * With a favorable liver function of Child-Pugh A to B * No contraindications to surgery and anesthesia * Diagnosed with Hepatolithiasis and portal hypertension * Signed informed consent.

Exclusion criteria

* Diffused type of Hepatolithiasis * Impairment in liver function * Severe disorders in vital organ * Accompanied with tumors.

Design outcomes

Primary

MeasureTime frameDescription
residual ratio of biliary stone3 monthsresidual ratio of biliary stone diagnosed within 3 months

Secondary

MeasureTime frameDescription
postoperative complications6 monthspostoperative complications diagnosed within 6 months
residual lesions6 monthsresidual lesions diagnosed within 6 months
Health economics index3 monthsHealth economics index within 3 months
mortality3 monthsmortality occured within 3 months

Countries

China

Contacts

Primary ContactXiaobin Feng, MD
fengxiaobin200708@aliyun.com+86-2368765297

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026